A new study by MIT researchers finds that delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer. The research further confirms Flow Pharma‘s approach by demonstrating a strong memory T cell response in the lungs of mice. The research article further explains that vaccination in the lungs can create a strong line of defense to fight viruses where the infections occur.